BioAge Labs, Inc. - Common Stock (NQ:BIOA)

6.610 -0.200 (-2.94%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioAge Labs, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

BioAge Labs Inc (NASDAQ:BIOA) Reports Q3 2025 Earnings with Significant Revenue Beat ↗

November 06, 2025

BioAge Labs reported a mixed Q3 2025, beating revenue estimates by 94% with a narrower EPS loss. The clinical-stage biotech advanced its lead drug, BGE-102, with cash runway through 2029.

Via Chartmill

BioAge Labs Reports Third Quarter 2025 Financial Results and Provides Business Updates

November 06, 2025

From BioAge Labs, Inc.

Via GlobeNewswire

Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy ↗

November 05, 2025

The bank's lead analyst recognizes the importance of getting in early with potentially game-changing drug development.

Via The Motley Fool

Could This Anti-Obesity Drug Biotech Be Poised to Soar in 2026? ↗

October 29, 2025

This stock has caught fire after some recent events, but how long will that last?

Via The Motley Fool

BioAge Labs Stock Just Soared. Does It Have More Fuel to Climb Higher? ↗

October 26, 2025

The clinical-stage biotech is working on a new type of weight management drug.

Via The Motley Fool

Here are the top movers in Thursday's session. ↗

October 23, 2025

Intrigued by the market activity one hour before the close of the markets on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 23, 2025

Via Benzinga

Which stocks are moving on Thursday? ↗

October 23, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

These stocks are gapping in today's session ↗

October 23, 2025

The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

October 23, 2025

Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 23, 2025

Via Benzinga

This Badger Meter Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday ↗

October 22, 2025

Via Benzinga

BIOAGE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

October 02, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

BioAge Labs to Present at Upcoming Investor Conferences

August 20, 2025

From BioAge Labs, Inc.

Via GlobeNewswire

BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor

August 15, 2025

From BioAge Labs, Inc.

Via GlobeNewswire

BioAge Labs (BIOA) Q2 Revenue Hits $2.4M ↗

August 06, 2025

Via The Motley Fool

Topics Intellectual Property

BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates

August 06, 2025

From BioAge Labs, Inc.

Via GlobeNewswire

BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

July 02, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

June 21, 2025

From BioAge Labs, Inc.

Via GlobeNewswire

BioAge Labs Expands Drug Discovery Platform with Data from Leading European Biobank

June 17, 2025

From BioAge Labs, Inc.

Via GlobeNewswire

BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates

June 03, 2025

From BioAge Labs, Inc.

Via GlobeNewswire

BioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic

May 29, 2025

From BioAge Labs, Inc.

Via GlobeNewswire

BioAge Labs to Present at Upcoming Investor Conferences

May 27, 2025

From BioAge Labs, Inc.

Via GlobeNewswire

BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

May 21, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates

May 06, 2025

From BioAge Labs, Inc.

Via GlobeNewswire

Notice to Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra LifeSciences Holdings Corporation (NASDAQ: IART); and Monolithic Power Systems, Inc. (NASDAQ: MPWR): Grabar Law Office Investigates

April 24, 2025

From Grabar Law Office

Via GlobeNewswire

Notice to Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Monolithic Power Systems, Inc. (NASDAQ: MPWR): Grabar Law Office Investigates

April 22, 2025

From Grabar Law Office

Via GlobeNewswire

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); NAPCO Security Technologies, Inc. (NASDAQ: NSSC); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VIRT)

April 17, 2025

From Grabar Law Office

Via GlobeNewswire

BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024

March 20, 2025

From BioAge Labs, Inc.

Via GlobeNewswire

BIOA DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class Action – BIOA

March 10, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.